Summary
Zoetis Inc. (ZTS) filed an 8-K on May 22, 2024, detailing the outcomes of its Annual Meeting of Shareholders held on May 20, 2024. Key events include the retirement of Dr. Linda Rhodes from the Board of Directors and shareholder approval of an amendment to the Restated Certificate of Incorporation to provide exculpation for certain officers, which became effective on May 22, 2024. The Annual Meeting saw high shareholder participation, with nearly 90% of voting power represented. Investors will note that all twelve director nominees were re-elected for one-year terms, and the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2024 was ratified. The company's executive compensation program received advisory approval, indicating shareholder confidence in the current remuneration structure. However, a shareholder proposal concerning the director resignation policy was not approved.
Key Highlights
- 1Dr. Linda Rhodes retired from the Board of Directors, effective May 21, 2024.
- 2Shareholders approved an amendment to the Restated Certificate of Incorporation to provide exculpation for certain officers, effective May 22, 2024.
- 3All twelve director nominees were elected for a one-year term until the 2025 Annual Meeting.
- 4The appointment of KPMG LLP as the independent registered public accounting firm for FY2024 was ratified.
- 5Shareholders provided advisory approval for the compensation program of named executive officers.
- 6A shareholder proposal regarding the director resignation policy was not approved.
- 7The Annual Meeting had a quorum with 89.68% of the voting power represented.